AF recurrence rate in the colchicine group was 31.1 % ( 32/103 ) vs 49.5 % ( 51/103 ) in the control group ( P = .010 ) , translated in a relative risk reduction of 37 % ( odds ratio 0.46 , 95 % confidence interval 0.26-0 .81 ) .